Pectin–chitosan physical hydrogels as potential drug delivery vehicles

International Journal of Biological Macromolecules

Volumn 101, Issue , 2017, Pages 852-861

  Neufeld, Lena ^a   Bianco Peled, Havazelet ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Chitosan; Drug delivery; Hydrogels; Pectin

Indexed keywords

CHITOSAN; CURCUMIN; DRUG CARRIER; DRUG VEHICLE; MESALAZINE; PECTIN; POLYMER; PROGESTERONE;

ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HYDROGEL; INFRARED SPECTROSCOPY; IONIC STRENGTH; MOLECULAR WEIGHT; RELEASE ASSAY; SUSTAINED DRUG RELEASE; THERMAL ANALYSIS; CHEMISTRY; DRUG RELEASE; METABOLISM; OSMOLARITY; STOMACH;

CHITOSAN; DRUG CARRIERS; DRUG LIBERATION; HYDROGELS; OSMOLAR CONCENTRATION; PECTINS; STOMACH;

EID: 85017108705     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2017.03.167     Document Type: Article

References (60)

1. [1] Rheology, C., Nordby, M.H., Kjøniksen, A., Nystro, B., Nyström, B., Roots, J., Thermoreversible gelation of aqueous mixtures of pectin and chitosan. Rheol. Biomacromol. 4 (2003), 337–343, 10.1021/bm020107+.
2. [2] Kumar, M.N.V.R., Muzzarelli, R.A.A., Muzzarelli, C., Sashiwa, H., Domb, A.J., Chitosan chemistry and pharmaceutical perspectives. Chem. Rev. 104 (2004), 6017–6084, 10.1021/cr030441b.
3. [3] Rinaudo, M., Chitin and chitosan: properties and applications. Prog. Polym. Sci. 31 (2006), 603–632, 10.1016/j.progpolymsci.2006.06.001.
4. [4] Aider, M., Chitosan application for active bio-based films production and potential in the food industry: review. LWT – Food Sci. Technol. 43 (2010), 837–842, 10.1016/j.lwt.2010.01.021.
5. [5] Muzzarelli, R.A.A., Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell. Mol. Life Sci. 53 (1997), 131–140, 10.1007/PL00000584.
6. [6] No, H., Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int. J. Food Microbiol. 74 (2002), 65–72, 10.1016/S0168-1605(01)00717-6.
7. [7] El Ghaouth, A., Antifungal activity of chitosan on two postharvest pathogens of strawberry fruits. Phytopathology, 82, 1992, 398, 10.1094/Phyto-82-398.
8. [8] Ravi Kumar, M.N., A review of chitin and chitosan applications. React. Funct. Polym. 46 (2000), 1–27, 10.1016/S1381-5148(00)00038-9.
9. [9] Borchard, G., Lueßen, H.L., de Boer, A.G., Verhoef, J.C., Lehr, C.-M., Junginger, H.E., The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro. J. Control. Release 39 (1996), 131–138, 10.1016/0168-3659(95)00146-8.
10. [10] Wong, T.W., Nurjaya, S., Drug release property of chitosan-pectinate beads and its changes under the influence of microwave. Eur. J. Pharm. Biopharm. 69 (2008), 176–188, 10.1016/j.ejpb.2007.09.015.
11. [11] Thakur, B.R., Singh, R.K., Handa, aK., Chemistry and uses of pectin – a review. Crit. Rev. Food Sci. Nutr. 37 (1997), 47–73, 10.1080/10408399709527767.
12. [12] Bawa, P., Choonara, Y.E., Du Toit, L.C., Kumar, P., Ndesendo, V.M.K., Meyer, L.C.R., Pillay, V., A novel stimuli-synchronized alloy-treated matrix for space-defined gastrointestinal delivery of mesalamine in the Large White pig model. J. Control. Release 166 (2013), 234–245, 10.1016/j.jconrel.2012.12.011.
13. [13] Bigucci, F., Luppi, B., Monaco, L., Cerchiara, T., Zecchi, V., Pectin-based microspheres for colon-specific delivery of vancomycin. J. Pharm. Pharmacol. 61 (2009), 41–46, 10.1211/jpp/61.01.0006.
14. [14] Bigucci, F., Luppi, B., Cerchiara, T., Sorrenti, M., Bettinetti, G., Rodriguez, L., Zecchi, V., Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin. Eur. J. Pharm. Sci. 35 (2008), 435–441, 10.1016/j.ejps.2008.09.004.
15. [15] Hiorth, M., Kjøniksen, A.-L., Knudsen, K.D., Sande, S.A., Nyström, B., Structural and dynamical properties of aqueous mixtures of pectin and chitosan. Eur. Polym. J. 41 (2005), 1718–1728, 10.1016/j.eurpolymj.2005.02.028.
16. [16] Ventura, I., Bianco-Peled, H., Small-angle X-ray scattering study on pectin–chitosan mixed solutions and thermoreversible gels. Carbohydr. Polym. 123 (2015), 122–129, 10.1016/j.carbpol.2015.01.025.
17. [17] Birch, N.P., Barney, L.E., Pandres, E., Peyton, S.R., Schiffman, J.D., Thermal-responsive behavior of a cell compatible chitosan/pectin hydrogel. Biomacromolecules 16 (2015), 1837–1843, 10.1021/acs.biomac.5b00425.
18. [18] Ritland, S.R., a Leighton, J., Hirsch, R.E., Morrow, J.D., Weaver, a.L., Gendler, S.J., Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse. Clin. Cancer Res. 5 (1999), 855–863.
19. [19] French, D.L., Mauger, J.W., Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery. Pharm. Res. 10 (1993), 1285–1290, 10.1023/A:1018909527659.
20. [20] Mangolim, C., Moriwaki, C., Nogueira, A., Sato, F., Baesso, M.L., Neto, A.M., Matioli, G., Curcumin–β-cyclodextrin inclusion complex: stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food. Food Chem. 153 (2014), 361–370.
21. [21] Pawar, Y.B., Munjal, B., Arora, S., Karwa, M., Kohli, G., Paliwal, J.K., Bansal, A.K., Bioavailability of a lipidic formulation of curcumin in healthy human volunteers. Pharmaceutics 4 (2012), 517–530, 10.3390/pharmaceutics4040517.
22. [22] Lama, R.Y.D., Bhujel, R.B., Rai, S., Joseph, S., Studies on solubility of curcumin. Int. J. Pharm. Life Sci. 3 (2012), 1533–1550.
23. [23] da Fonseca, E., Bittar, R., Carvalho, M.H.B., Zugaib, M., Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am. J. Obstet. Gynecol. 188 (2003), 419–424.
24. [24] Dahan, A., Hoffman, A., Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats. Pharm. Res. 23 (2006), 2165–2174, 10.1007/s11095-006-9054-x.
25. [25] Nandi, I., Bateson, M., Bari, M., Joshi, H.N., Synergistic effect of PEG-400 and cyclodextrin to enhance solubility of progesterone. AAPS PharmSciTech, 4, 2003, E1, 10.1208/pt040101.
26. [26] Delmar, K., Bianco-Peled, H., Composite chitosan hydrogels for extended release of hydrophobic drugs. Carbohydr. Polym. 136 (2016), 570–580, 10.1016/j.carbpol.2015.09.072.
27. [27] Marudova, M., MacDougall, A.J., Ring, S.G., Pectin–chitosan interactions and gel formation. Carbohydr. Res. 339 (2004), 1933–1939, 10.1016/j.carres.2004.05.017.
28. [28] Cui, F., Qin, L., Li, F., Luo, H., Synchronous fluorescence determination and molecular modeling of 5-Aminosalicylic acid (5-ASA) interacted with human serum albumin. J. Mol. Model. 14 (2008), 1111–1117, 10.1007/s00894-008-0352-6.
29. [29] Fadda, H.M., Sousa, T., Carlsson, A.S., Abrahamsson, B., Williams, J.G., Kumar, D., Basit, A.W., Drug solubility in luminal fluids from different regions of the small and large intestine of humans. Mol. Pharm. 7 (2010), 1527–1532, 10.1021/mp100198q.
30. [30] Costa, P., Sousa Lobo, J.M., Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13 (2001), 123–133, 10.1016/S0928-0987(01)00095-1.
31. [31] Ritger, P.L., Peppas, N.A., A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Release 5 (1987), 37–42, 10.1016/0168-3659(87)90035-6.
32. [32] Romero, P., Costa, J., Castel-maroteaux, I., Chulia, D., Statistical optimization of a controlled release formulation obtained by a double compression process: application of a Hadamard matrix and a factorial design. Drug Dev. Ind. Pharm., 15, 1989.
33. [33] Peppas, N.A., Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60 (1985), 110–111.
34. [34] Sing, C.E., Zwanikken, J.W., de la Cruz, M.O., Effect of ion–ion correlations on polyelectrolyte gel collapse and reentrant swelling. Macromolecules 46 (2013), 5053–5065, 10.1021/ma400372p.
35. [35] Rubinstein, R., Colby, M., Polymer Physics. 2003, Oxford Univ. Press, New York.
36. [36] Bajpai, A., Giri, A., Water sorption behaviour of highly swelling (carboxy methylcellulose-g-polyacrylamide) hydrogels and release of potassium nitrate as agrochemical. Carbohydr. Polym. 53 (2003), 271–279, 10.1016/S0144-8617(03)00071-7.
37. [37] Tanaka, T., Experimental Methods in Polymer Science: Modern Methods in Polymer Research and Technology. 2000.
38. ® MP in fluidized bed. J. Appl. Polym. Sci., 131, 2014, 10.1002/app.40444.
39. [39] Tummala, S., Satish Kumar, M.N., Prakash, A., Formulation and characterization of 5-fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer. Saudi Pharm. J. 23 (2015), 308–314, 10.1016/j.jsps.2014.11.010.
40. [40] Palugan, L., Cerea, M., Zema, L., Gazzaniga, A., Maroni, A., Coated pellets for oral colon delivery. J. Drug Deliv. Sci. Technol. 25 (2015), 1–15, 10.1016/j.jddst.2014.12.003.
41. [41] Mura, C., Nácher, A., Merino, V., Merino-Sanjuan, M., Carda, C., Ruiz, A., Manconi, M., Loy, G., Fadda, A.M., Diez-Sales, O., N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats. Int. J. Pharm. 416 (2011), 145–154, 10.1016/j.ijpharm.2011.06.025.
42. [42] Sarmento, B., Martins, S., Ribeiro, A., Veiga, F., Neufeld, R., Ferreira, D., Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers. Int. J. Pept. Res. Ther. 12 (2006), 131–138.
43. [43] Borges, O., Borchard, G., Verhoef, J., de Sousa, A., Junginger, H.E., Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int. J. Pharm. 299 (2005), 155–166.
44. [44] Sarmento, B., Ferreira, D., Veiga, F., Ribeiro, A., Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr. Polym., 2006.
45. [45] Aguzzi, C., Ortega, A., Bonferoni, M.C., Sandri, G., Cerezo, P., Salcedo, I., Sánchez, R., Viseras, C., Caramella, C., Assessement of anti-inflammatory properties of microspheres prepared with chitosan and 5-amino salicylic acid over inflamed Caco-2 cells. Carbohydr. Polym. 85 (2011), 638–644, 10.1016/j.carbpol.2011.03.027.
46. [46] Narayana Charyulu, J.J., Akshaya Bhandarkar, Harish, N., Investigation on release profile of chitosan based polyelectrolyte complexes using an antihypertensive agent – ProQuest. Int. J. Pharm. Sci. Rev. Res. 15:1 (2012), 88–94 18.
47. [47] Paramera, E.I., Konteles, S.J., Karathanos, V.T., Stability and release properties of curcumin encapsulated in Saccharomyces cerevisiae, β-cyclodextrin and modified starch. Food Chem. 125 (2011), 913–922, 10.1016/j.foodchem.2010.09.071.
48. [48] Paradkar, A., Ambike, A.A., Jadhav, B.K., Mahadik, K.R., Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int. J. Pharm. 271 (2004), 281–286, 10.1016/j.ijpharm.2003.11.014.
49. [49] Yang, L., Gao, S., Asghar, S., Liu, G., Song, J., Wang, X., Ping, Q., Zhang, C., Xiao, Y., Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells. Int. J. Biol. Macromol. 72 (2015), 1391–1401, 10.1016/j.ijbiomac.2014.10.039.
50. [50] Echezarreta-López, M., Torres-Labandeira, J., Castiñeiras-Seijo, L., Santana-Penı́n, L., Vila-Jato, J., Complexation of the interferon inducer, bropirimine, with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci. 9 (2000), 381–386, 10.1016/S0928-0987(99)00081-0.
51. [51] McCann, M.C., Hammouri, M., Wilson, R., Belton, P., Roberts, K., Fourier transform infrared microspectroscopy is a new way to look at plant cell walls. Plant Physiol. 100 (1992), 1940–1947.
52. [52] Orioli, M., Marinello, C., Cozzi, R., Piodi, L.P., Carini, M., LC–MS/MS and FT-IR analyses of stones from a patient with Crohn's disease: a case report. J. Pharm. Biomed. Anal. 35 (2004), 1263–1272, 10.1016/j.jpba.2004.03.016.
53. [53] Kolev, T.M., Velcheva, E.A., Stamboliyska, B.A., Spiteller, M., DFT and experimental studies of the structure and vibrational spectra of curcumin. Int. J. Quantum Chem. 102 (2005), 1069–1079, 10.1002/qua.20469.
54. [54] Mohan, P.R.K., Sreelakshmi, G., Muraleedharan, C.V., Joseph, R., Water soluble complexes of curcumin with cyclodextrins: characterization by FT-Raman spectroscopy. Vib. Spectrosc. 62 (2012), 77–84, 10.1016/j.vibspec.2012.05.002.
55. [55] Paramera, E.I., Konteles, S.J., Karathanos, V.T., Microencapsulation of curcumin in cells of Saccharomyces cerevisiae. Food Chem. 125 (2011), 892–902, 10.1016/j.foodchem.2010.09.063.
56. [56] Anitha, A., Deepagan, V.G., Divya Rani, V.V., Menon, D., Nair, S.V., Jayakumar, R., Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles. Carbohydr. Polym. 84 (2011), 1158–1164, 10.1016/j.carbpol.2011.01.005.
57. [57] Ribeiro, L.N.M., Alcântara, A.C.S., Darder, M., Aranda, P., Araújo-Moreira, F.M., Ruiz-Hitzky, E., Pectin-coated chitosan-LDH bionanocomposite beads as potential systems for colon-targeted drug delivery. Int. J. Pharm. 463 (2014), 1–9, 10.1016/j.ijpharm.2013.12.035.
58. [58] Gupta, M.K., Vanwert, A., Bogner, R.H., Formation of physically stable amorphous drugs by milling with neusilin. J. Pharm. Sci. 92 (2003), 536–551, 10.1002/jps.10308.
59. [59] Uekama, K., Fujinaga, T., Hirayama, F., Otagiri, M., Yamasaki, M., Inclusion complexations of steroid hormones with cyclodextrins in water and in solid phase. Int. J. Pharm. 10 (1982), 1–15, 10.1016/0378-5173(82)90057-6.
60. [60] Cerchiara, T., Luppi, B., Bigucci, F., Zecchi, V., Effect of chitosan on progesterone release from hydroxypropyl-β-cyclodextrin complexes. Int. J. Pharm. 258 (2003), 209–215, 10.1016/S0378-5173(03)00202-3.